|
C1ORF174 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.706050E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.842020E-01 |
| Normal-vs-Stage2 |
5.262000E-01 |
| Normal-vs-Stage3 |
5.725800E-01 |
| Normal-vs-Stage4 |
3.099600E-01 |
| Stage1-vs-Stage2 |
9.519600E-01 |
| Stage1-vs-Stage3 |
6.266000E-01 |
| Stage1-vs-Stage4 |
9.421400E-01 |
| Stage2-vs-Stage3 |
8.133400E-01 |
| Stage2-vs-Stage4 |
9.181600E-01 |
| Stage3-vs-Stage4 |
6.773800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.008800E-01 |
| Normal-vs-AfricanAmerican |
7.073800E-01 |
| Normal-vs-Asian |
7.155800E-02 |
| Caucasian-vs-AfricanAmerican |
8.065600E-01 |
| Caucasian-vs-Asian |
8.626000E-02 |
| AfricanAmerican-vs-Asian |
8.341600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.408000E-01 |
| Normal-vs-Female |
3.946300E-02 |
| Male-vs-Female |
1.544210E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.368200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.912200E-02 |
| Normal-vs-Age(61-80Yrs) |
5.058000E-01 |
| Normal-vs-Age(81-100Yrs) |
5.482600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.540400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.210200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.309400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.473170E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.215780E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.557600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.415320E-03 |
| Normal-vs-Grade 2 |
4.497900E-02 |
| Normal-vs-Grade 3 |
8.949200E-01 |
| Normal-vs-Grade 4 |
2.196400E-01 |
| Grade 1-vs-Grade 2 |
1.219230E-01 |
| Grade 1-vs-Grade 3 |
2.310400E-02 |
| Grade 1-vs-Grade 4 |
1.670180E-01 |
| Grade 2-vs-Grade 3 |
3.118100E-02 |
| Grade 2-vs-Grade 4 |
9.151400E-01 |
| Grade 3-vs-Grade 4 |
1.657040E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.017600E-03 |
| Normal-vs-ccB subtype |
9.187600E-01 |
| ccA subtype-vs-ccB subtype |
9.884500E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.778800E-01 |
| Normal-vs-N1 |
9.191900E-02 |
| N0-vs-N1 |
1.265640E-01 |
|
|
